Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203

Andre Konski,Snehal Deshmukh,Ann H. Klopp,Anamaria R. Yeung,Shannon N. Westin,J. Spencer Thompson,Desiree E. Doncals,Guilherme H.C. Cantuaria,David P. D'Souza,Amy Chang,Vijayananda Kundapur,Dasarahally S. Mohan,Michael L. Haas,Yong Bae Kim,Catherine L. Ferguson,Stephanie L. Pugh,Lisa A. Kachnic,Deborah W. Bruner

Gynecologic Oncology（2023）

引用 0|浏览8

暂无评分

摘要

•The first randomized clinical trial comparing two types of radiotherapy in gynecologic malignancies.•Utilities were measured a priori to calculate quality-adjusted survival between the two treatment arms.•Although not powered for these endpoints, non-statistically significant improvements were seen with the use of IMRT.

查看译文

关键词

Utilities, Intensity modulated radiotherapy (IMRT), Patient reported outcomes, Endometrial cancer, Cervical cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要